Skip to main content

Phreesia Inc

For the period ended Jan 31, 2024. Filed Mar 15, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 15, 2024

PHR$12.90+2.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 16. Form 10-K Summary

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

PHREESIA, INC.
Date: March 15, 2024By:/s/ Chaim Indig
Name: Chaim Indig
Title: Chief Executive Officer

POWER OF ATTORNEY AND SIGNATURES

Each individual whose signature appears below hereby constitutes and appoints each of Chaim Indig and Balaji Gandhi as such person’s true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such person’s name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that any said attorney-in-fact and agent, or any substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

NameTitleDate
/s/ Chaim IndigChief Executive Officer and Director (Principal Executive Officer)March 15, 2024
Chaim Indig
/s/ Balaji GandhiChief Financial Officer(Principal Financial Officer)March 15, 2024
Balaji Gandhi
/s/ Janet GunzburgVP, Controller (Principal Accounting Officer)March 15, 2024
Janet Gunzburg
/s/ Michael WeintraubChairman and DirectorMarch 15, 2024
Michael Weintraub
/s/ Edward CahillDirectorMarch 15, 2024
Edward Cahill
/s/ Lisa Egbuonu-Davis, M.D.DirectorMarch 15, 2024
Lisa Egbuonu-Davis, M.D.
/s/ Lainie GoldsteinDirectorMarch 15, 2024
Lainie Goldstein
/s/ Gillian MunsonDirectorMarch 15, 2024
Gillian Munson
/s/ Ramin SayarDirectorMarch 15, 2024
Ramin Sayar
/s/ Mark Smith, M.D.DirectorMarch 15, 2024
Mark Smith, M.D.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.